Insights
UnitedHealth Group Q2 2026 Earnings Analysis
The most significant finding from UnitedHealth Group’s Q1 2026 results is not the beat itself—it is what the beat signals about the trajectory of the turnaround.
July 17, 2026
Analysis, playbooks, and research for government-sponsored health plans navigating a faster, more competitive market.
The most significant finding from UnitedHealth Group’s Q1 2026 results is not the beat itself—it is what the beat signals about the trajectory of the turnaround.
Elevance Q2 2026 earnings beat estimates by 20%, yet shares fell 8.54% as Medicaid concerns dominated the call. Get the full HealthWorks AI breakdown.
Network adequacy is no longer a competitive position in Medicare Advantage. Here is how leading health plans are moving from compliance to sculpting ahead of 2027 bids.
Seven of the largest MA payers reported Q1 2026. Read across the calls and the message is unambiguous. Here is what each one signaled, what they said collectively, and what it means for your AEP 2027 positioning
CVS Health’s Q1 2026 results delivered the clearest Aetna recovery signal the company has posted in two years.
Alignment’s Q1 2026 numbers tell a different story than the rest of the industry. Membership grew 30.9% to 284,800. Adjusted EBITDA grew 87.6% to $37.9 million. Both came in above the company’s own guidance.
The healthcare payer industry is changing rapidly—and our resources help you stay on top of it all. Sign up to get new insights, success stories, and more, sent right to your inbox.
Thanks for subscribing — keep an eye on your inbox for our next resource.